AlphaCrest Capital Management’s Exelixis EXEL Stock Holding History

AlphaCrest Capital Management’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-175,367	Closed	-$2.75M	–	391
2022 Q3	$2.75M	Buy	175,367 +132,670	+311%	+$2.56M	0.17%	121
2022 Q2	$889K	Sell	42,697 -32,886	-44%	-$678K	0.04%	711
2022 Q1	$1.71M	Sell	75,583 -64,469	-46%	-$1.26M	0.1%	300
2021 Q4	$2.56M	Buy	140,052 +82,012	+141%	+$1.57M	0.1%	307
2021 Q3	$1.23M	Sell	58,040 -18,160	-24%	-$337K	0.06%	521
2021 Q2	$1.39M	Buy	76,200 +61,323	+412%	+$1.43M	0.06%	507
2021 Q1	$336K	Buy	+14,877	New	+$336K	0.02%	972
2020 Q4	–	Sell	-12,335	Closed	-$302K	–	1160
2020 Q3	$302K	Buy	12,335 +2,274	+23%	+$53.1K	0.03%	852
2020 Q2	$239K	Sell	10,061 -10,674	-51%	-$247K	0.04%	744
2020 Q1	$357K	Buy	+20,735	New	+$379K	0.04%	718
2019 Q4	–	Sell	-64,000	Closed	-$1.13M	–	1279
2019 Q3	$1.13M	Buy	64,000 +51,800	+425%	+$1.05M	0.07%	503
2019 Q2	$261K	Sell	12,200 -34,600	-74%	-$725K	0.02%	900
2019 Q1	$1.11M	Buy	46,800 +29,200	+166%	+$666K	0.17%	150
2018 Q4	$346K	Buy	+17,600	New	+$314K	0.1%	390

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AlphaCrest Capital Management's EXEL Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Exelixis (EXEL) in Q4 2022, closing a stake of 175,367 shares — an estimated $2.75M sold.

AlphaCrest Capital Management first reported a position in EXEL in Q4 2018 and held it in 14 quarters. The position peaked at $2.75M in Q3 2022. 386 funds tracked by Wall St. Rank hold EXEL as of Q4 2022.

AlphaCrest Capital Management reported no remaining Exelixis position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 175,367 Exelixis shares in Q4 2022, an estimated $2.75M.
AlphaCrest Capital Management first reported a position in Exelixis in Q4 2018 and held it in 14 quarters.
AlphaCrest Capital Management's Exelixis position peaked at $2.75M in Q3 2022.
386 funds tracked by Wall St. Rank held Exelixis as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.